Acute Lung Injury Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 17
SKU : PH2175
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Acute Lung Injury Market ?
Acute Lung Injury Market is expected to grow at a CAGR of 5.8% during the forecast period 2024-2031
Who are the key players in Acute Lung Injury Market ?
Major players are Altor BioScience Corporation, GlaxoSmithKline Plc, Gilead Sciences Inc., Commence Bio, Inc., CompleGen, Inc., Histocell S.L., Windtree Therapeutics, Inc., Navigen Pharmaceuticals, Inc., Silence Therapeutics plc, Quark Pharmaceuticals, Inc., and Ono Pharmaceutical Co., Ltd.
Related Reports
medical-devicesPortable Lung Monitors Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 16
Starting from
$4350
information-communication-and-technologyWater Cut Monitors Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 January 24
Starting from
$4350
information-communication-and-technologyPortable Printer Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 April 06
Starting from
$4350
medical-devicesPortable Vein Finder Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 November 02
Starting from
$4350
medical-devicesFertility Monitors Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 November 06
Starting from
$4350
information-communication-and-technologyPortable Data Storage Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 January 19
Starting from
$4350